Blood test may spare some transplant patients from chemo
Disease control
Recruiting now
This study tests whether a blood test (ctDNA) can help doctors choose the right treatment for people with a type of lymphoma that happens after an organ transplant (PTLD). About 30 participants will be split into low-risk and high-risk groups. Low-risk patients will get only the …
Phase: PHASE2 • Sponsor: Jennifer Amengual • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC